| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +492772.09% |
| VRNA | Verona Pharma Plc | $77.75B | +344730.91% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +289456.55% |
| ARGX | Argen X SE | $54.32B | +240838.36% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +173471.34% |
| ONC | BeiGene Ltd | $34.73B | +153948.34% |
| RVMD | Revolution Medicines Inc | $30.63B | +135740.54% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +104455.13% |
| BNTX | BioNTech SE | $23.52B | +104209.77% |
| INSM | Insmed Inc | $23.04B | +102079.46% |
| ROIV | Roivant Sciences Ltd | $21.31B | +94406.88% |
| INCY | Incyte Corp | $19.46B | +86223.60% |
| MRNA | Moderna Inc | $18.90B | +83731.83% |
| GMAB | Genmab | $17.06B | +75547.03% |
| ASND | Ascendis Pharma A/S | $15.18B | +67224.91% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +65120.51% |
| SMMT | Summit Therapeutics Inc | $13.47B | +59650.49% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +57571.04% |
| EXEL | Exelixis Inc | $12.69B | +56195.40% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +56182.93% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +53826.38% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +53385.49% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +49147.94% |
| ABVX | Abivax | $10.29B | +45523.18% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +44800.14% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +44028.60% |
| CYTK | Cytokinetics Inc | $9.51B | +42081.71% |
| KRYS | Krystal Biotech Inc | $9.03B | +39933.95% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +37367.51% |
| IBRX | ImmunityBio Inc | $8.26B | +36550.97% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +35988.05% |
| TECH | Bio-Techne Corp | $7.53B | +33283.67% |
| MTSR | Metsera Inc | $7.40B | +32741.61% |
| PCVX | Vaxcyte Inc | $7.36B | +32556.69% |
| CORT | Corcept Therapeutics Inc | $6.96B | +30772.12% |
| MRUS | Merus N.V | $6.83B | +30173.77% |
| IMVT | Immunovant Inc | $6.81B | +30120.38% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +29679.65% |
| ACLX | Arcellx Inc | $6.67B | +29465.20% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +29016.00% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +28703.85% |
| CELC | Celcuity Inc | $6.48B | +28627.70% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +27652.60% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +27192.76% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +26650.97% |
| TGTX | TG Therapeutics Inc | $6.00B | +26517.31% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +26279.19% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +26200.91% |
| COGT | Cogent Biosciences Inc | $5.89B | +26038.85% |
| PTCT | PTC Therapeutics Inc | $5.86B | +25874.92% |
| APGE | Apogee Therapeutics Inc | $5.82B | +25722.62% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +25255.02% |
| BLTE | Belite Bio Inc | $5.59B | +24692.35% |
| CGON | Cg Oncology Inc | $5.35B | +23632.57% |
| LEGN | Legend Biotech Corp | $5.26B | +23251.23% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +23179.33% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +22999.07% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +22783.86% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +20881.88% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +20855.07% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +19877.68% |
| TVTX | Travere Therapeutics Inc | $4.41B | +19473.75% |
| AKRO | Akero Therapeutics Inc | $4.38B | +19327.18% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +19180.87% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +18813.86% |
| ERAS | Erasca Inc | $3.88B | +17090.06% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +17084.47% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +16872.54% |
| VKTX | Viking Therapeutics Inc | $3.67B | +16173.91% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +15979.27% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +15888.85% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +14535.06% |
| BEAM | Beam Therapeutics Inc | $3.28B | +14431.89% |
| DNLI | Denali Therapeutics Inc | $3.21B | +14121.45% |
| RCUS | Arcus Biosciences Inc | $3.01B | +13242.34% |
| DYN | Dyne Therapeutics Inc | $3.00B | +13206.06% |
| ORKA | ARCA biopharma Inc | $2.91B | +12803.18% |
| TNGX | Tango Therapeutics Inc | $2.83B | +12464.21% |
| GPCR | Structure Therapeutics Inc | $2.81B | +12363.48% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +12059.65% |
| RLAY | Relay Therapeutics Inc | $2.73B | +12009.59% |
| ALMS | Alumis Inc | $2.67B | +11730.33% |
| IRON | Disc Medicine Inc | $2.66B | +11716.30% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +11629.69% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +11360.12% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +11309.42% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +11083.27% |
| IMNM | Immunome Inc | $2.50B | +10998.02% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +10874.96% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +10764.21% |
| ETNB | 89bio Inc | $2.34B | +10291.59% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +10097.74% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +9733.96% |
| KOD | Kodiak Sciences Inc | $2.18B | +9573.52% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +9244.71% |
| ZLAB | Zai Lab Ltd | $2.08B | +9103.30% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +8913.28% |
| MESO | Mesoblast Ltd | $2.02B | +8851.07% |
| TYRA | Tyra Biosciences Inc | $1.97B | +8649.06% |
| SION | Sionna Therapeutics Inc | $1.96B | +8582.65% |
| STOK | Stoke Therapeutics Inc | $1.96B | +8581.86% |
| NBTX | Nanobiotix | $1.94B | +8489.77% |
| AAPG | Ascentage Pharma Group International | $1.93B | +8471.72% |
| PHVS | Pharvaris NV | $1.92B | +8435.89% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +8391.44% |
| GLPG | Galapagos NV | $1.90B | +8319.33% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +8277.66% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +8191.21% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +8129.82% |
| ADMA | Adma Biologics Inc | $1.84B | +8059.70% |
| NVAX | Novavax Inc | $1.82B | +7987.48% |
| ZYME | Zymeworks BC Inc | $1.81B | +7937.67% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +7911.85% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +7794.79% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +7743.45% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +7710.19% |
| VCEL | Vericel Corp | $1.75B | +7653.36% |
| OCS | Oculis Holding AG | $1.74B | +7635.94% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +7601.16% |
| BHVN | Biohaven Ltd | $1.70B | +7436.50% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +7432.64% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +7360.54% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +7352.80% |
| ANAB | AnaptysBio Inc | $1.67B | +7328.13% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +7280.76% |
| ABCL | AbCellera Biologics Inc | $1.65B | +7233.56% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +7226.37% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +7184.61% |
| INVA | Innoviva Inc | $1.63B | +7144.44% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +7079.88% |
| NKTR | Nektar Therapeutics | $1.62B | +7075.11% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +7069.38% |
| QURE | uniQure N.V. | $1.59B | +6936.77% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +6904.32% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +6838.54% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +6800.54% |
| PGEN | Precigen Inc | $1.55B | +6783.58% |
| IMTX | Immatics N.V | $1.53B | +6701.96% |
| ARDX | Ardelyx Inc | $1.52B | +6658.58% |
| MBX | MBX Biosciences Inc | $1.52B | +6626.30% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +6573.09% |
| VIR | Vir Biotechnology Inc | $1.47B | +6407.56% |
| IMCR | Immunocore Holdings plc | $1.45B | +6329.93% |
| URGN | UroGen Pharma Ltd | $1.43B | +6236.29% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +6173.71% |
| GHRS | GH Research PLC | $1.39B | +6052.08% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +5988.09% |
| SEPN | Septerna Inc | $1.34B | +5834.68% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +5825.18% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +5719.73% |
| MAZE | Maze Therapeutics Inc | $1.30B | +5646.63% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +5530.72% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +5420.30% |
| TRML | Tourmaline Bio Inc | $1.24B | +5380.78% |
| WVE | Wave Life Sciences Ltd | $1.22B | +5308.46% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +4905.27% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +4900.63% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +4771.00% |
| MNKD | Mannkind Corp | $1.10B | +4763.81% |
| DBVT | DBV Technologies | $1.10B | +4758.21% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +4722.42% |
| SVRA | Savara Inc | $1.07B | +4635.29% |
| JBIO | Jade Biosciences Inc | $1.06B | +4605.55% |
| CVAC | CureVac N.V. | $1.05B | +4553.96% |
| ANNX | Annexon Inc | $1.05B | +4542.57% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +4290.33% |
| CGEM | Cullinan Oncology Inc | $953.73M | +4130.03% |
| PHAR | Pharming Group N.V. | $940.58M | +4071.74% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +3997.25% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +3953.12% |
| KURA | Kura Oncology Inc | $908.93M | +3931.37% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +3916.67% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +3838.14% |
| JANX | Janux Therapeutics Inc | $878.90M | +3798.15% |
| XNCR | Xencor Inc | $868.03M | +3749.95% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +3684.22% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +3643.60% |
| GERN | Geron Corp | $843.41M | +3640.76% |
| EVMN | Evommune Inc | $841.03M | +3630.19% |
| VOR | Vor Biopharma Inc | $840.96M | +3629.89% |
| TBPH | Theravance Biopharma Inc | $837.63M | +3615.13% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +3602.12% |
| SANA | Sana Biotechnology Inc | $825.64M | +3561.94% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +3472.62% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +3435.62% |
| OMER | Omeros Corporation | $797.02M | +3435.02% |
| ABSI | Absci Corp | $789.28M | +3400.69% |
| CMRX | Chimerix Inc | $766.03M | +3297.55% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +3277.47% |
| ANRO | Alto Neuroscience Inc | $714.55M | +3069.22% |
| ATXS | Astria Therapeutics Inc | $709.95M | +3048.83% |
| DSGN | Design Therapeutics Inc | $693.10M | +2974.09% |
| SLDB | Solid Biosciences Inc | $690.73M | +2963.58% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +2929.99% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +2895.63% |
| CRMD | CorMedix Inc | $663.22M | +2841.58% |
| IVA | Inventiva | $655.21M | +2806.05% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +2770.99% |
| CABA | Cabaletta Bio Inc | $640.38M | +2740.28% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +2736.84% |
| PRME | Prime Medicine Inc | $596.03M | +2543.56% |
| CADL | Candel Therapeutics Inc | $589.73M | +2515.59% |
| CBIO | Crescent Biopharma Inc | $573.22M | +2442.39% |
| TECX | AvroBio Inc | $573.01M | +2441.46% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +2433.92% |
| ARVN | Arvinas Inc | $570.83M | +2431.76% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +2343.11% |
| VALN | Valneva SE | $545.52M | +2319.54% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +2307.40% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +2298.22% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +2287.50% |
| MDXG | Mimedx Group Inc | $537.64M | +2284.59% |
| PRTA | Prothena Corporation plc | $532.36M | +2261.18% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +2206.23% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +2125.78% |
| XOMA | XOMA Corp | $497.12M | +2104.85% |
| STRO | Sutro Biopharma Inc | $491.87M | +2081.57% |
| OCGN | Ocugen Inc | $466.88M | +1970.74% |
| SVA | Sinovac Biotech Ltd | $464.94M | +1962.13% |
| IMMX | Immix Biopharma Inc | $462.80M | +1952.62% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +1951.77% |
| STTK | Shattuck Labs Inc | $458.03M | +1931.47% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +1902.98% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +1902.13% |
| UPB | Upstream Bio Inc | $449.51M | +1893.70% |
| AUTL | Autolus Therapeutics plc | $447.12M | +1883.10% |
| ADCT | Adc Therapeutics SA | $438.08M | +1843.02% |
| ASMB | Assembly Biosciences Inc | $435.45M | +1831.34% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +1817.92% |
| AURA | Aura Biosciences Inc | $430.49M | +1809.34% |
| OVID | Ovid Therapeutics Inc | $424.86M | +1784.36% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +1761.02% |
| IPSC | Century Therapeutics Inc | $415.14M | +1741.24% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +1713.74% |
| CMPX | Compass Therapeutics Inc | $408.80M | +1713.14% |
| CYBN | Cybin Inc | $408.43M | +1711.51% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +1690.80% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +1688.37% |
| BNTC | Benitec Biopharma Inc | $398.51M | +1667.50% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +1631.02% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +1630.59% |
| CCCC | C4 Therapeutics Inc | $389.10M | +1625.75% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +1622.98% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +1600.10% |
| RVNC | Revance Therapeutics Inc | $380.38M | +1587.08% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +1585.88% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +1572.55% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +1572.03% |
| OABI | OmniAb Inc | $374.99M | +1563.18% |
| REPL | Replimune Group Inc | $374.27M | +1559.97% |
| ALT | Altimmune Inc | $373.67M | +1557.35% |
| VSTM | Verastem Inc | $373.33M | +1555.83% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +1554.02% |
| PBYI | Puma Biotechnology Inc | $371.93M | +1549.60% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +1521.84% |
| CLLS | Cellectis | $364.91M | +1518.49% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +1514.99% |
| EDIT | Editas Medicine Inc | $349.39M | +1449.62% |
| PALI | Palisade Bio Inc | $346.56M | +1437.10% |
| RGNX | Regenxbio Inc | $345.32M | +1431.58% |
| IMRX | Immuneering Corp Class A | $344.95M | +1429.97% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +1427.39% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +1422.55% |
| FBRX | Forte Biosciences Inc | $340.15M | +1408.67% |
| IMAB | I-Mab | $339.64M | +1406.38% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +1383.87% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +1357.82% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +1348.47% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +1347.14% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +1342.80% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +1335.12% |
| SLN | Silence Therapeutics Plc | $321.20M | +1324.59% |
| RZLT | Rezolute Inc | $319.69M | +1317.91% |
| IVVD | Invivyd Inc | $319.57M | +1317.37% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +1312.91% |
| ANL | Adlai Nortye Ltd | $317.46M | +1308.00% |
| SCPH | scPharmaceuticals Inc | $304.59M | +1250.94% |
| NAGE | Niagen Bioscience Inc | $304.32M | +1249.74% |
| SRZN | Surrozen Inc | $304.03M | +1248.44% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +1243.27% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +1212.05% |
| IRD | Ocuphire Pharma Inc | $295.61M | +1211.09% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +1183.21% |
| ACIU | AC Immune SA | $289.11M | +1182.29% |
| TENX | Tenax Therapeutics Inc | $288.39M | +1179.10% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +1168.70% |
| YDES | YD Bio Ltd | $278.91M | +1137.04% |
| MGNX | Macrogenics Inc | $278.39M | +1134.75% |
| FATE | Fate Therapeutics Inc | $275.57M | +1122.21% |
| CNTX | Context Therapeutics Inc | $273.80M | +1114.38% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +1109.41% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +1094.13% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +1069.58% |
| TARA | Protara Therapeutics Inc | $262.06M | +1062.33% |
| CGEN | Compugen Ltd | $260.97M | +1057.46% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +1041.55% |
| CHRS | Coherus Biosciences Inc | $256.00M | +1035.44% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +1034.43% |
| HUMA | Humacyte Inc | $255.32M | +1032.42% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +1011.90% |
| ALEC | Alector Inc | $245.37M | +988.26% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +974.97% |
| THRD | Third Harmonic Bio Inc | $241.86M | +972.74% |
| CDXS | Codexis Inc | $239.96M | +964.29% |
| ADAG | Adagene Inc | $236.93M | +950.84% |
| NKTX | Nkarta Inc | $236.88M | +950.64% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +933.47% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +927.17% |
| NERV | Minerva Neurosciences Inc | $230.61M | +922.81% |
| SLRN | Acelyrin Inc | $228.54M | +913.66% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +900.60% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +895.52% |
| CRBU | Caribou Biosciences Inc | $223.96M | +893.31% |
| KROS | Keros Therapeutics Inc | $223.18M | +889.86% |
| RNA | Atrium Therapeutics Inc | $222.37M | +886.29% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +869.58% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +865.65% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +811.85% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +797.90% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +795.06% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +790.39% |
| KRRO | Korro Bio Inc | $198.45M | +780.20% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +777.36% |
| DTIL | Precision Biosciences Inc | $195.87M | +768.72% |
| IMUX | Immunic Inc | $190.70M | +745.81% |
| QTTB | Q32 Bio Inc | $187.99M | +733.78% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +723.33% |
| MDWD | MediWound Ltd | $184.49M | +718.24% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +713.69% |
| THAR | Tharimmune Inc | $183.00M | +711.65% |
| IFRX | InflaRx N.V. | $182.18M | +708.01% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +701.95% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +691.39% |
| GALT | Galectin Therapeutics Inc | $177.81M | +688.65% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +669.71% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +665.52% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +665.51% |
| HRTX | Heron Therapeutics Inc | $172.54M | +665.26% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +662.36% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +658.41% |
| SPRO | Spero Therapeutics Inc | $169.62M | +652.32% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +650.80% |
| THTX | Theratechnologies Inc | $167.34M | +642.18% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +638.98% |
| EQ | Equillium Inc | $166.29M | +637.52% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +631.43% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +629.00% |
| MENS | Jyong Biotech Ltd | $164.22M | +628.36% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +622.44% |
| IPHA | Innate Pharma | $159.97M | +609.51% |
| TTRX | Turn Therapeutics Inc | $157.58M | +598.90% |
| MOLN | Molecular Partners AG | $154.89M | +586.96% |
| HURA | TuHURA Biosciences Inc | $151.32M | +571.13% |
| NBP | NovaBridge Biosciences. | $150.91M | +569.34% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | +567.54% |
| AKTX | Akari Therapeutics Plc | $148.12M | +556.97% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +544.70% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +537.87% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +535.38% |
| PROK | ProKidney Corp - Class A | $137.85M | +511.40% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +510.41% |
| GNLX | Genelux Corp | $137.21M | +508.57% |
| GUTS | Fractyl Health Inc | $136.31M | +504.58% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +487.08% |
| AGEN | Agenus Inc | $131.36M | +482.61% |
| ACOG | Alpha Cognition Inc | $124.77M | +453.37% |
| CRDF | Cardiff Oncology Inc | $123.75M | +448.86% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +434.36% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +432.37% |
| SEER | Seer Inc - Class A | $115.64M | +412.90% |
| ENGN | enGene Holdings Inc | $115.22M | +411.04% |
| RPTX | Repare Therapeutics Inc | $113.91M | +405.23% |
| COYA | Coya Therapeutics Inc | $111.89M | +396.27% |
| PYXS | Pyxis Oncology Inc | $108.70M | +382.11% |
| VANI | Vivani Medical Inc | $108.35M | +380.56% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +371.61% |
| HLVX | HilleVax Inc | $104.74M | +364.55% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +363.55% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +361.73% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +357.49% |
| PEPG | PepGen Inc | $103.13M | +357.40% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +354.19% |
| BMEA | Biomea Fusion Inc | $98.33M | +336.11% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +333.78% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +333.51% |
| ICCC | Immucell Corp | $96.17M | +326.53% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +316.63% |
| ATHA | Athira Pharma Inc | $92.15M | +308.71% |
| FBIO | Fortress Biotech Inc | $91.60M | +306.25% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +302.96% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +297.92% |
| ANIX | Anixa Biosciences Inc | $88.68M | +293.31% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +290.73% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +286.83% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +286.08% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +285.83% |
| PYPD | Polypid Ltd | $86.83M | +285.13% |
| NRXS | Neuraxis Inc | $85.30M | +278.34% |
| LPTX | Leap Therapeutics Inc | $84.76M | +275.93% |
| CSBR | Champions Oncology Inc | $82.35M | +265.24% |
| ACET | Adicet Bio Inc | $81.58M | +261.83% |
| HYFT | MindWalk Holdings Corp | $79.54M | +252.79% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +252.51% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +245.61% |
| FBIOP | Fortress Biotech Inc | $77.72M | +244.71% |
| RLYB | Rallybio Corp | $76.87M | +240.93% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +240.51% |
| GANX | Gain Therapeutics Inc | $75.20M | +233.55% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +231.24% |
| XBIT | XBiotech Inc | $74.39M | +229.94% |
| OSTX | OS Therapies Inc | $74.24M | +229.26% |
| MCRB | Seres Therapeutics Inc | $73.19M | +224.62% |
| SAVA | Cassava Sciences Inc. | $72.46M | +221.39% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +219.01% |
| EDSA | Edesa Biotech Inc | $70.82M | +214.10% |
| BYSI | BeyondSpring Inc | $70.31M | +211.87% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +204.76% |
| SPRB | Spruce Biosciences Inc | $67.96M | +201.40% |
| CUE | Cue Biopharma Inc | $66.52M | +195.05% |
| IMA | Ikena Oncology Inc | $66.48M | +194.87% |
| MNOV | Medicinova Inc | $65.46M | +190.35% |
| IBIO | iBio Inc | $64.94M | +188.03% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +185.26% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +183.85% |
| IMMP | Immutep Ltd | $63.92M | +183.51% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +181.88% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +180.50% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +180.40% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +174.79% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +171.67% |
| GLTO | Galecto Inc | $60.81M | +169.71% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +162.57% |
| ANVS | Annovis Bio Inc | $57.22M | +153.77% |
| DWTX | Virios Therapeutics Inc | $57.12M | +153.33% |
| ENTX | Entera Bio Ltd | $55.48M | +146.07% |
| TIL | Instil Bio Inc | $55.21M | +144.85% |
| KZR | Kezar Life Sciences Inc | $53.76M | +138.44% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +134.33% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +133.79% |
| NBY | Stablecoin Development Corp | $52.10M | +131.07% |
| RNTX | Rein Therapeutics Inc | $51.79M | +129.72% |
| GOSS | Gossamer Bio Inc | $51.14M | +126.82% |
| MGX | Metagenomi Inc | $50.82M | +125.42% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +121.90% |
| INKT | MiNK Therapeutics Inc | $48.84M | +116.63% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +114.84% |
| XLO | Xilio Therapeutics Inc | $48.23M | +113.90% |
| CING | Cingulate Inc | $47.16M | +109.15% |
| ATYR | Atyr Pharma Inc | $46.89M | +107.96% |
| LVTX | LAVA Therapeutics NV | $45.77M | +103.01% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +102.81% |
| PSTV | Plus Therapeutics Inc | $45.56M | +102.09% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +95.55% |
| KALA | Kala Bio Inc | $43.31M | +92.11% |
| RNXT | RenovoRx Inc | $41.96M | +86.09% |
| NTRB | Nutriband Inc | $41.39M | +83.58% |
| HYPD | Eyenovia Inc | $41.14M | +82.48% |
| FGEN | FibroGen Inc | $39.31M | +74.33% |
| NNVC | NanoViricides Inc | $37.88M | +68.02% |
| VERU | Veru Inc | $37.40M | +65.87% |
| LTRN | Lantern Pharma Inc | $37.25M | +65.23% |
| INMB | INmune Bio Inc | $37.22M | +65.08% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +62.81% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +60.14% |
| GRCE | Acasti Pharma Inc | $36.05M | +59.91% |
| GBIO | Generation Bio Company | $35.97M | +59.53% |
| ABVC | ABVC BioPharma Inc | $35.82M | +58.86% |
| MURA | Mural Oncology plc | $35.34M | +56.75% |
| LITS | Lite Strategy Inc | $35.16M | +55.93% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +53.70% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +52.13% |
| DARE | Dare Bioscience Inc | $33.92M | +50.46% |
| EVAX | Evaxion Biotech A/S | $33.82M | +50.00% |
| BOLD | Boundless Bio Inc | $32.94M | +46.09% |
| SNTI | Senti Biosciences Inc | $31.46M | +39.52% |
| TVRD | Cara Therapeutics Inc | $30.96M | +37.31% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +33.30% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +32.94% |
| APLM | Apollomics Inc - Class A | $29.93M | +32.75% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +29.28% |
| SKYE | Skye Bioscience Inc | $29.10M | +29.08% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +28.79% |
| GRDX | Entero Therapeutics Inc | $28.95M | +28.42% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +26.79% |
| CRVO | CervoMed Inc | $28.15M | +24.84% |
| IGC | IGC Pharma Inc | $28.00M | +24.18% |
| DYAI | Dyadic International Inc DE | $27.40M | +21.52% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +21.38% |
| SER | AgeX Therapeutics Inc | $26.82M | +18.95% |
| PLRZ | Polyrizon Ltd | $26.52M | +17.62% |
| CELU | Celularity Inc - Class A | $26.39M | +17.04% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +16.91% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +16.73% |
| PTN | Palatin Technologies Inc | $26.08M | +15.65% |
| TPST | Tempest Therapeutics Inc | $25.68M | +13.88% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +12.05% |
| PLUR | Pluri Inc | $24.62M | +9.18% |
| MRKR | Marker Therapeutics Inc | $24.21M | +7.40% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +5.61% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | -1.02% |
| HOTH | Hoth Therapeutics Inc | $22.13M | -1.86% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | -2.62% |
| NXTC | Nextcure Inc | $21.90M | -2.88% |
| OPT | Opthea Ltd | $21.53M | -4.51% |
| CRIS | Curis Inc | $21.11M | -6.38% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | -9.63% |
| LGVN | Longeveron Inc - Class A | $19.70M | -12.61% |
| GNTA | Genenta Science SpA | $19.23M | -14.73% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | -14.74% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | -16.18% |
| XCUR | Exicure Inc | $17.78M | -21.13% |
| INAB | IN8bio Inc | $17.72M | -21.39% |
| PASG | Passage Bio Inc | $17.71M | -21.46% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | -23.35% |
| MTVA | MetaVia Inc | $17.25M | -23.50% |
| LPCN | Lipocine Inc | $17.04M | -24.41% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | -26.59% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | -28.52% |
| HIND | ReShape Lifesciences Inc | $15.72M | -30.27% |
| COCP | Cocrystal Pharma Inc | $15.44M | -31.51% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | -31.52% |
| LEXX | Lexaria Bioscience Corp | $15.24M | -32.41% |
| CLRB | Cellectar Biosciences Inc | $14.97M | -33.61% |
| QNCX | Quince Therapeutics Inc | $14.89M | -33.94% |
| APLT | Applied Therapeutics Inc | $14.86M | -34.08% |
| HOOK | Hookipa Pharma Inc | $14.68M | -34.90% |
| BLRX | Bioline Rx Ltd | $14.66M | -34.96% |
| MBRX | Moleculin Biotech Inc | $14.57M | -35.39% |
| IOBT | IO Biotech Inc | $14.50M | -35.70% |
| ICU | SeaStar Medical Holding Corp | $14.34M | -36.41% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | -37.26% |
| GTBP | GT Biopharma Inc | $13.91M | -38.32% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | -39.39% |
| TOVX | Theriva Biologics Inc | $13.51M | -40.10% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | -40.74% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | -42.25% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | -42.39% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | -43.32% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | -45.30% |
| CALC | CalciMedica Inc | $11.72M | -48.00% |
| LNAI | Lunai Bioworks Inc | $11.72M | -48.04% |
| TRAW | Traws Pharma Inc | $11.70M | -48.12% |
| INTS | Intensity Therapeutics Inc | $11.33M | -49.75% |
| BIVI | BioVie Inc - Class A | $11.16M | -50.49% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | -50.58% |
| BRTX | BioRestorative Therapies Inc | $11.03M | -51.08% |
| APRE | Aprea Therapeutics Inc | $10.96M | -51.39% |
| KAPA | Kairos Pharma Ltd | $10.68M | -52.61% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -53.76% |
| CVM | Cel-Sci Corp | $10.15M | -55.00% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | -55.09% |
| MLEC | Moolec Science SA | $10.06M | -55.39% |
| BCDA | BioCardia Inc | $9.85M | -56.31% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | -56.51% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | -56.85% |
| SNGX | Soligenix Inc | $9.11M | -59.61% |
| IMNN | Imunon Inc | $9.02M | -59.98% |
| EPIX | Essa Pharma Inc | $8.93M | -60.39% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -60.45% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | -60.98% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | -61.40% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | -62.13% |
| IMRN | Immuron Ltd | $8.36M | -62.93% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | -63.81% |
| LIMN | Liminatus Pharma Inc | $8.08M | -64.17% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -64.25% |
| NCNA | NuCana plc | $7.95M | -64.75% |
| ADXN | Addex Therapeutics Ltd | $7.90M | -64.97% |
| SYBX | Synlogic Inc | $7.72M | -65.75% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | -66.00% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -67.46% |
| XBIO | Xenetic Biosciences Inc | $7.06M | -68.67% |
| GNPX | Genprex Inc | $7.02M | -68.86% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | -69.04% |
| EVGN | Evogene Ltd | $6.91M | -69.33% |
| SILO | SILO Pharma Inc | $6.78M | -69.91% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | -70.09% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | -70.36% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -71.61% |
| GOVX | Geovax Labs Inc | $6.29M | -72.12% |
| APM | Aptorum Group Ltd - Class A | $6.26M | -72.25% |
| BCAB | BioAtla Inc | $6.19M | -72.54% |
| PPBT | Purple Biotech Ltd | $6.05M | -73.17% |
| APVO | Aptevo Therapeutics Inc | $5.83M | -74.16% |
| BGMS | Bio Green Med Solution Inc | $5.30M | -76.50% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | -76.71% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -76.81% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | -77.03% |
| HCWB | HCW Biologics Inc | $5.10M | -77.39% |
| PULM | Pulmatrix Inc | $4.97M | -77.97% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -78.22% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | -78.24% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | -79.24% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | -79.30% |
| ALZN | Alzamend Neuro Inc | $4.38M | -80.59% |
| MBIO | Mustang Bio Inc | $4.29M | -80.97% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -81.08% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -81.09% |
| REVB | Revelation Biosciences Inc | $4.26M | -81.10% |
| FBLG | FibroBiologics Inc | $4.23M | -81.26% |
| ENVB | Enveric Biosciences Inc | $4.15M | -81.58% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -81.65% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | -81.90% |
| PHGE | BiomX Inc | $3.91M | -82.68% |
| PBM | Psyence Biomedical Ltd | $3.76M | -83.31% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | -83.51% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | -84.00% |
| VIVS | VivoSim Labs Inc | $3.36M | -85.08% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -85.18% |
| AZTR | Azitra Inc | $3.32M | -85.27% |
| GRI | GRI Bio Inc | $3.30M | -85.38% |
| SPRC | SciSparc Ltd | $3.05M | -86.49% |
| AFMD | Affimed N.V. | $2.98M | -86.80% |
| CMND | Clearmind Medicine Inc | $2.88M | -87.22% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -87.24% |
| ARTL | Artelo Biosciences Inc | $2.75M | -87.82% |
| OGEN | Oragenics Inc | $2.58M | -88.57% |
| PPCB | Propanc Biopharma Inc | $2.50M | -88.90% |
| NTBL | Notable Labs Inc Ord | $2.39M | -89.38% |
| BBLG | Bone Biologics Corp | $2.23M | -90.13% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -90.48% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -90.74% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -91.15% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -92.26% |
| ONCO | Onconetix Inc | $1.61M | -92.85% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -93.09% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -93.11% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -93.11% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -93.26% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -93.67% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -93.86% |
| JAGX | Jaguar Health Inc | $1.34M | -94.04% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -94.23% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -95.53% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -95.92% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -97.56% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -98.02% |
| ELAB | PMGC Holdings Inc | $221376.00 | -99.02% |
| ADTX | Aditxt Inc | $132564.52 | -99.41% |
| CDT | CDT Equity Inc | $110551.31 | -99.51% |